Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease | MicrobiomeTrials← Back to trialsNCT07619547
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-06-14Est. Completion: 2036-06-01
Enrollment target: 100 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Type 2 DiabetesDiabetes Mellitus Type 2
AIM-MET is a randomized clinical study testing whether a fixed microbiome-targeted nutritional product can improve blood…
Izmir, Turkey (Türkiye)Est. completion Mar 30, 2027
Inflammatory Bowel Disease
Crohn's Disease (CD) and Ulcerative Colitis (UC), collectively known as inflammatory bowel disease (IBD), are two of the…
Chicago, United StatesEst. completion Sep 1, 2026